A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

In a significant medical breakthrough, researchers from King’s College London have found that semaglutide, a drug commonly ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance in Ozempic and Wegovy can halt and even reverse a ...

The report emphasized the progress of pegozafermin through Phase 3 clinical development, with positive results from Phase ...